| Bioactivity | SRI 37892 is a small molecule compound inhibitor of Frizzled protein 7 (Fzd7) with inhibitory activity against cancer cell proliferation (IC502μM). SRI 37892 significantly blocks Wnt/Fzd7 signaling. SRI 3789 can be used in the research of developing cancer therapeutic agents [1]. |
| Target | 2μM (Fzd7) |
| Name | SRI 37892 |
| CAS | 1030769-75-5 |
| Formula | C26H19N5O2S |
| Molar Mass | 465.53 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zhang W, et al. Discovery of novel frizzled-7 inhibitors by targeting the receptor's transmembrane domain. Oncotarget. 2017 Sep 6;8(53):91459-91470. |
SRI 37892
CAS: 1030769-75-5 F: C26H19N5O2S W: 465.53
SRI 37892 is a small molecule compound inhibitor of Frizzled protein 7 (Fzd7) with inhibitory activity against cancer ce
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.